Literature DB >> 21239455

Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages.

Quan M Nhu1, Kari Ann Shirey, Meghan E Pennini, Jennifer Stiltz, Stefanie N Vogel.   

Abstract

Proteinase-activated receptor 2 (PAR(2)), a 7-transmembrane G protein-coupled receptor, contributes to inflammation either positively or negatively in different experimental systems. Previously, we reported that concurrent activation of PAR(2) and TLRs in human lung and colonic epithelial cells resulted in a synergistic increase in NF-κB-mediated gene expression, but a down-regulation of IRF-3-mediated gene expression. In this study, the effect of PAR(2) activation on LPS-induced TLR4 signaling was examined in primary murine macrophages. The PAR(2) activation of wild-type macrophages enhanced LPS-induced expression of the anti-inflammatory cytokine, IL-10, while suppressing gene expression of pro-inflammatory cytokines, TNF-α, IL-6, and IL-12. Similar PAR(2)-mediated effects on LPS-stimulated IL-10 and IL-12 mRNA were also observed in vivo. In contrast, PAR 2-/- macrophages exhibited diminished LPS-induced IL-10 mRNA and protein expression and downstream STAT3 activation, but increased KC mRNA and protein. PAR(2) activation also enhanced both rIL-4- and LPS-induced secretion of IL-4 and IL-13, and mRNA expression of alternatively activated macrophage (AA-M) markers, e.g. arginase-1, mannose receptor, Ym-1. Thus, in the context of a potent inflammatory stimulus like LPS, PAR(2) activation acts to re-establish tissue homeostasis by dampening the production of inflammatory mediators and causing the differentiation of macrophages that may contribute to the development of a Th2 response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21239455      PMCID: PMC3724520          DOI: 10.1177/1753425910395044

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  51 in total

Review 1.  Regulation of interleukin-12 production by G-protein-coupled receptors.

Authors:  M C Braun; B L Kelsall
Journal:  Microbes Infect       Date:  2001-02       Impact factor: 2.700

Review 2.  Protease-activated receptors: novel PARtners in innate immunity.

Authors:  V Shpacovitch; M Feld; N W Bunnett; M Steinhoff
Journal:  Trends Immunol       Date:  2007-10-30       Impact factor: 16.687

Review 3.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

4.  The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection.

Authors:  A Kawabata; M Kinoshita; H Nishikawa; R Kuroda; M Nishida; H Araki; N Arizono; Y Oda; K Kakehi
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

5.  PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release.

Authors:  Ewa Ostrowska; Elena Sokolova; Georg Reiser
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-08-31       Impact factor: 5.464

6.  Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism.

Authors:  Kari Ann Shirey; Leah E Cole; Achsah D Keegan; Stefanie N Vogel
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

7.  Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.

Authors:  Prasad Rallabhandi; Quan M Nhu; Vladimir Y Toshchakov; Wenji Piao; Andrei E Medvedev; Morley D Hollenberg; Alessio Fasano; Stefanie N Vogel
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

8.  G-protein-dependent and -independent pathways regulate proteinase-activated receptor-2 mediated p65 NFkappaB serine 536 phosphorylation in human keratinocytes.

Authors:  Fui Goon Goh; Callum M Sloss; Margaret R Cunningham; Mary Nilsson; Laurence Cadalbert; Robin Plevin
Journal:  Cell Signal       Date:  2008-02-29       Impact factor: 4.315

9.  Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells.

Authors:  A Uehara; T Imamura; J Potempa; J Travis; H Takada
Journal:  Cell Microbiol       Date:  2008-01-07       Impact factor: 3.715

10.  Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome.

Authors:  Anaïs Briot; Céline Deraison; Matthieu Lacroix; Chrystelle Bonnart; Aurélie Robin; Céline Besson; Pierre Dubus; Alain Hovnanian
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

View more
  24 in total

1.  Roles of PAR1 and PAR2 in viral myocarditis.

Authors:  Nigel Mackman; Silvio Antoniak
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 2.  Multiple roles of the coagulation protease cascade during virus infection.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

3.  Neutral high-generation phosphorus dendrimers inhibit macrophage-mediated inflammatory response in vitro and in vivo.

Authors:  I Posadas; L Romero-Castillo; N El Brahmi; D Manzanares; S Mignani; J-P Majoral; V Ceña
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-28       Impact factor: 11.205

Review 4.  Tissue factor pathways linking obesity and inflammation.

Authors:  W Ruf; F Samad
Journal:  Hamostaseologie       Date:  2015-01-27       Impact factor: 1.778

5.  Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Cong Lin; Jan von der Thüsen; Joost Daalhuisen; Marieke ten Brink; Bruno Crestani; Tom van der Poll; Keren Borensztajn; C Arnold Spek
Journal:  Mol Med       Date:  2015-06-29       Impact factor: 6.354

Review 6.  Parasites, nutrition, immune responses and biology of metabolic tissues.

Authors:  T Shea-Donohue; B Qin; A Smith
Journal:  Parasite Immunol       Date:  2017-03-22       Impact factor: 2.280

Review 7.  Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.

Authors:  Ian M Carroll; Nitsan Maharshak
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

8.  Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.

Authors:  H M H Spronk; T Padro; J E Siland; J H Prochaska; J Winters; A C van der Wal; J J Posthuma; G Lowe; E d'Alessandro; P Wenzel; D M Coenen; P H Reitsma; W Ruf; R H van Gorp; R R Koenen; T Vajen; N A Alshaikh; A S Wolberg; F L Macrae; N Asquith; J Heemskerk; A Heinzmann; M Moorlag; N Mackman; P van der Meijden; J C M Meijers; M Heestermans; T Renné; S Dólleman; W Chayouâ; R A S Ariëns; C C Baaten; M Nagy; A Kuliopulos; J J Posma; P Harrison; M J Vries; H J G M Crijns; E A M P Dudink; H R Buller; Y M C Henskens; A Själander; S Zwaveling; O Erküner; J W Eikelboom; A Gulpen; F E C M Peeters; J Douxfils; R H Olie; T Baglin; A Leader; U Schotten; B Scaf; H M M van Beusekom; L O Mosnier; L van der Vorm; P Declerck; M Visser; D W J Dippel; V J Strijbis; K Pertiwi; A J Ten Cate-Hoek; H Ten Cate
Journal:  Thromb Haemost       Date:  2018-01-29       Impact factor: 5.249

9.  Activated factor X signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells.

Authors:  Eimear M Gleeson; James S O'Donnell; Emily Hams; Fionnuala Ní Áinle; Bridget-Ann Kenny; Padraic G Fallon; Roger J S Preston
Journal:  Haematologica       Date:  2013-07-19       Impact factor: 9.941

10.  PAR-1 contributes to the innate immune response during viral infection.

Authors:  Silvio Antoniak; A Phillip Owens; Martin Baunacke; Julie C Williams; Rebecca D Lee; Alice Weithäuser; Patricia A Sheridan; Ronny Malz; James P Luyendyk; Denise A Esserman; JoAnn Trejo; Daniel Kirchhofer; Burns C Blaxall; Rafal Pawlinski; Melinda A Beck; Ursula Rauch; Nigel Mackman
Journal:  J Clin Invest       Date:  2013-02-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.